Steiner, David J <br/><br/>
Pharmaceuticals and Medical Devices: Cost Savings.  [electronic resource] 

 -  Issue brief (Health Policy Tracking Service)  Dec 2016 
 - 1-31 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticonvulsants--economics<br/>Biological Products--economics<br/>Biosimilar Pharmaceuticals--economics<br/>Canada<br/>Centers for Medicare and Medicaid Services, U.S.--economics<br/>Chronic Disease<br/>Commerce<br/>Cost Savings<br/>Deductibles and Coinsurance<br/>Drug Approval--economics<br/>Drug Costs--legislation & jurisprudence<br/>Drugs, Generic--economics<br/>Economics, Pharmaceutical--legislation & jurisprudence<br/>Epinephrine--economics<br/>Financial Audit<br/>Humans<br/>Imatinib Mesylate--economics<br/>Insurance Benefits--economics<br/>Insurance Coverage--economics<br/>Insurance, Pharmaceutical Services--economics<br/>Legislation, Drug--economics<br/>Medication Adherence<br/>Medication Therapy Management--economics<br/>Naloxone--economics<br/>Pharmacies--economics<br/>State Government<br/>Therapeutic Equivalency<br/>United States<br/>United States Food and Drug Administration--economics